Cardiac myxoma is the most common benign cardiac tumor. Although it has a very low reported incidence of 0.5-1 per 1,000,000 person-years, it is a potentially devastating cause of cardioembolic stroke. About 12% of cardiac myxoma cases are associated with neurologic disorders, most commonly ischemic stroke. 1 Surgical resection is the treatment of choice, and the recurrence rate was reportedly less than 1% per year, predominantly within 4 years. 2 Transthoracic echocardiographic screening is currently recommended in postoperative settings, but there is little evidence over appropriate duration or periods of follow-up strategies. Here we report a patient who presented with recurrent cardiac myxoma revealed by an embolic stroke event that occurred 12 years after complete resection, which had gone undetected during 9 years of routine echocardiographic follow-ups.
Recurrent Stroke due to Relapsing Cardiac Myxoma JCN result in a physician facing embolic stroke with a history of myxoma resection overlooking the possibility of recurrence. However, the time interval between the embolic event and surgical resection is known to be the sole contributor of embolism recurrence, 2 and so timely diagnosis and management are important. There are a few reports on recurrent ischemic stroke due to recurrent myxoma, but in all cases the recurrence was detected within 10 years postoperatively. 6, 7 Nevertheless, embolic stroke due to myxoma recurrence could occur even with an echocardiographically proven long tumorfree period, and so clinical suspicion is necessary. In the present case, the transient cutaneous manifestation in both hands suggested that Janeway lesion could be a clue for cardioembolic stroke, which has also been reported in myxoma. 8 A long tumor-free interval since myxoma resection should therefore not be used to exclude a cardiac etiology of stroke, and a thorough neurologic evaluation with etiologic assessments are imperative to ensure appropriate diagnosis and management.
This case was subject to a particular limitation. Some cardiac myxomas are genetically associated with known Carney com-plex, presenting as skin pigmentation, endocrinopathy, and tumors. Familial predisposition with autosomal dominant pattern is seen, and cardiac myxoma could occur in multiple forms with any cardiac chamber in Carney complex. The present patient exhibited recurrent myxoma in the atrium without a familial predisposition nor clinical features compatible with Carney complex, and so the likelihood of Carney-complex-associated myxoma is assumed to be low, resulting in genetic confirmation of mutations in PRKAR1A not being performed. Nonetheless, reports concerning long-latency recurrence or neurologic manifestation of Carney complex are also lacking, and so further case studies are necessary. 
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